Anti-tumor activity of the farnesyl-protein transferase inhibitors arteminolides, isolated from Artemisa

Cited 58 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorSeung Ho Lee-
dc.contributor.authorMi Young Lee-
dc.contributor.authorHyun Mi Kang-
dc.contributor.authorDong Cho Han-
dc.contributor.authorKwang Hee Son-
dc.contributor.authorD C Yang-
dc.contributor.authorN D Sung-
dc.contributor.authorChang Woo Lee-
dc.contributor.authorHwan Mook Kim-
dc.contributor.authorByoung-Mog Kwon-
dc.date.accessioned2017-04-19T09:00:21Z-
dc.date.available2017-04-19T09:00:21Z-
dc.date.issued2003-
dc.identifier.issn0968-0896-
dc.identifier.uri10.1016/j.bmc.2003.08.008ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/6253-
dc.description.abstractMembers of the Artemisia genus are important medicinal plants found throughout the world. Arteminolides A-D (1-4), isolated from the aerial parts of Artemisia, have an inhibitory activity on farnesyl-protein transferase (FPTase; EC 2.5.1.29) in in vitro assay. This study was carried out with the purpose of validating anti-tumor effects of the compounds in human tumor cells and mouse xenograft model. The arteminolides inhibited tumor cell growth in a dose-dependent manner. Furthermore, arteminolide C (3) blocked in vivo growth of human colon and lung tumor xenograft without the loss of body weight in nude mice.-
dc.publisherElsevier-
dc.titleAnti-tumor activity of the farnesyl-protein transferase inhibitors arteminolides, isolated from Artemisa-
dc.title.alternativeAnti-tumor activity of the farnesyl-protein transferase inhibitors arteminolides, isolated from Artemisa-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry-
dc.citation.number21-
dc.citation.endPage4549-
dc.citation.startPage4545-
dc.citation.volume11-
dc.contributor.affiliatedAuthorSeung Ho Lee-
dc.contributor.affiliatedAuthorMi Young Lee-
dc.contributor.affiliatedAuthorHyun Mi Kang-
dc.contributor.affiliatedAuthorDong Cho Han-
dc.contributor.affiliatedAuthorKwang Hee Son-
dc.contributor.affiliatedAuthorChang Woo Lee-
dc.contributor.affiliatedAuthorHwan Mook Kim-
dc.contributor.affiliatedAuthorByoung-Mog Kwon-
dc.contributor.alternativeName이승호-
dc.contributor.alternativeName이미영-
dc.contributor.alternativeName강현미-
dc.contributor.alternativeName한동초-
dc.contributor.alternativeName손광희-
dc.contributor.alternativeName양덕조-
dc.contributor.alternativeName성낙도-
dc.contributor.alternativeName이창우-
dc.contributor.alternativeName김환묵-
dc.contributor.alternativeName권병목-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry, vol. 11, no. 21, pp. 4545-4549-
dc.identifier.doi10.1016/j.bmc.2003.08.008-
dc.description.journalClassY-
Appears in Collections:
Division of A.I. & Biomedical Research > Genomic Medicine Research Center > 1. Journal Articles
Division of A.I. & Biomedical Research > Microbiome Convergence Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.